It is recommended that patients with MI should be treated with beta-blockers, angiotensin-converting enzyme inhibitors, or angiotensin-receptor blocker and statins as it has been proven that these drugs improve the prognosis of patients after MI (16, 17). This evidence concerns the gene ACE and myocardial infarction.